Profound Medical (PROF) Income towards Parent Company (2024 - 2026)

Profound Medical's Income towards Parent Company history runs 3 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 34.21% year-over-year to -$7.1 million; the TTM figure through Mar 2026 stood at -$38.9 million (down 919.71% YoY), while the FY2025 annual figure was -$42.5 million, down 13232.41% from the prior year.
• Income towards Parent Company was -$7.1 million for Q1 2026 at Profound Medical, up from -$8.2 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $23.2 million in Q4 2024 to a low of -$15.7 million in Q2 2025.
• Historically, Income towards Parent Company has averaged -$5.5 million across 3 years, with a median of -$8.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Income towards Parent Company plunged 135.19% in 2025, then soared 34.21% in 2026.
• A 3-year view of Income towards Parent Company shows it stood at $23.2 million in 2024, then tumbled by 135.19% to -$8.2 million in 2025, then increased by 13.55% to -$7.1 million in 2026.
• The last three Income towards Parent Company figures came in at -$7.1 million (Q1 2026), -$8.2 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.